Regeneron Pharmaceuticals, Inc.

Bronte Capital Management Pty Ltd. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/3/2026

Shares

176,768

Value ($000)

136,442

Weight

14.3%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/3/2026	136,442	14%	176,768	12/31/2025
2025 Q3	11/5/2025	113,281	10%	180,283	9/30/2025
2025 Q2	8/12/2025	111,075	8.7%	187,870	6/30/2025